Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 10 studies | 25% ± 12% | |
| GABAergic neuron | 6 studies | 42% ± 17% | |
| T follicular helper cell | 5 studies | 42% ± 17% | |
| endothelial cell of artery | 5 studies | 28% ± 8% | |
| CD16-negative, CD56-bright natural killer cell, human | 4 studies | 27% ± 13% | |
| oligodendrocyte precursor cell | 4 studies | 32% ± 10% | |
| interneuron | 4 studies | 25% ± 9% | |
| T cell | 3 studies | 30% ± 15% | |
| glutamatergic neuron | 3 studies | 38% ± 18% | |
| group 3 innate lymphoid cell | 3 studies | 38% ± 12% | |
| neuron | 3 studies | 17% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 30% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 99% | 666.33 | 648 / 653 | 95% | 13.65 | 572 / 605 |
| prostate | 99% | 1391.07 | 243 / 245 | 94% | 8.54 | 471 / 502 |
| lung | 100% | 2836.53 | 578 / 578 | 89% | 8.27 | 1029 / 1155 |
| esophagus | 97% | 2099.92 | 1398 / 1445 | 90% | 15.45 | 164 / 183 |
| uterus | 90% | 531.64 | 153 / 170 | 78% | 10.72 | 359 / 459 |
| bladder | 100% | 1541.05 | 21 / 21 | 68% | 6.43 | 341 / 504 |
| stomach | 94% | 586.89 | 339 / 359 | 73% | 4.56 | 209 / 286 |
| intestine | 89% | 582.05 | 862 / 966 | 73% | 4.71 | 387 / 527 |
| brain | 73% | 703.49 | 1926 / 2642 | 87% | 10.62 | 612 / 705 |
| adrenal gland | 67% | 246.09 | 174 / 258 | 79% | 8.48 | 181 / 230 |
| breast | 88% | 523.40 | 406 / 459 | 56% | 2.97 | 629 / 1118 |
| skin | 71% | 430.68 | 1287 / 1809 | 63% | 7.52 | 299 / 472 |
| kidney | 69% | 269.72 | 61 / 89 | 65% | 6.94 | 590 / 901 |
| ovary | 49% | 186.07 | 88 / 180 | 81% | 7.12 | 350 / 430 |
| liver | 38% | 126.00 | 85 / 226 | 73% | 6.65 | 298 / 406 |
| spleen | 94% | 429.97 | 227 / 241 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 93% | 59.16 | 27 / 29 |
| adipose | 91% | 611.22 | 1100 / 1204 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 91% | 9.86 | 41 / 45 |
| pancreas | 2% | 4.93 | 7 / 328 | 86% | 5.81 | 153 / 178 |
| blood vessel | 74% | 666.17 | 983 / 1335 | 0% | 0 | 0 / 0 |
| peripheral blood | 30% | 523.71 | 277 / 929 | 0% | 0 | 0 / 0 |
| heart | 28% | 85.21 | 238 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 25% | 1.17 | 20 / 80 |
| muscle | 6% | 22.26 | 47 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0031490 | Molecular function | chromatin DNA binding |
| GO_0003713 | Molecular function | transcription coactivator activity |
| Gene name | TOX2 |
| Protein name | TOX high mobility group box family member 2 TOX high mobility group box family member 2 (Granulosa cell HMG box protein 1) (GCX-1) |
| Synonyms | GCX1 C20orf100 |
| Description | FUNCTION: Putative transcriptional activator involved in the hypothalamo-pituitary-gonadal system. |
| Accessions | Q96NM4 Q5JYD4 ENST00000341197.9 [Q96NM4-4] ENST00000413823.1 ENST00000423191.6 [Q96NM4-3] ENST00000372999.5 [Q96NM4-3] ENST00000358131.5 [Q96NM4-1] |